The London Patient: 30 Months Free of HIV

Emerging from the shadows a year after his case stunned the world, Adam Castillejo still shows no signs of the virus.

• Deploying Data Against HIV and COVID-19
• Shape-Shifting Viral Proteins: Key to HIV and COVID-19 Vaccines
• Does ART Adequately Reach Tissue Reservoirs of HIV?
• amfAR Second Largest Funder of HIV Cure Research Worldwide

Assessing the Impact of Covid-19 on Black Americans

New amfAR study finds that disproportionately black counties account for 52% and 58% of COVID-19 cases and deaths, respectively.

• Know Your Status. Know Your Risk.
• Long-Acting Antiretroviral Blocks HIV
• Context Matters - Health Insurance Coverage Is Fundamental to Ending the HIV Epidemic
• Policy Responses: Parallels Between HIV and COVID-19

COVID-19 Pandemic Threatens HIV Drug Supplies

Supply chain disruptions caused by the COVID-19 pandemic are disrupting the availability of HIV drugs in the Asia-Pacific.

• Former TREAT Asia Student Researcher Named Student Who Rocked Public Health
• An Interview With Dr. Adeeba Kamarulzaman
• NIH Awards Research Training Grant to TREAT Asia–Columbia University Collaboration

International AIDS Conference Goes Virtual

amfAR will feature prominently at the world's largest meeting for the HIV field, which will "convene" July 6-10.

A Conversation with the San Francisco Patient

Loreen Willenberg talks about her inspirational journey living with HIV from her diagnosis to participating in clinical research.

Intersections #8: HIV and COVID-19 – DNA Vaccine

amfAR-funded HIV researcher Dr. Dan Barouch of Harvard Medical School talks to amfAR’s Dr. Rowena Johnston about his team’s efforts to rapidly develop a safe and effective vaccine against the coronavirus.

HIV & COVID-19

In this special section of our website, we are constantly gathering new information to keep you updated on the intersection between HIV and COVID-19.